These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 528672)

  • 1. Determination of an aromatic retinoid and its main metabolite by high-performance liquid chromatography.
    Hänni R; Hervouet D; Busslinger A
    J Chromatogr; 1979 Apr; 162(4):615-21. PubMed ID: 528672
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
    Thongnopnua P; Zimmerman CL
    J Chromatogr; 1988 Dec; 433():345-51. PubMed ID: 2976770
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
    Jakobsen P; Larsen FG; Larsen CG
    J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
    Palmskog G
    J Chromatogr; 1980 Dec; 221(2):345-51. PubMed ID: 6452462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline of plasma concentrations of etretinate and its main metabolite after treatment.
    Lauharanta J; Paravicini U; Kanerva L; Lassus A
    Arch Dermatol Res; 1982; 274(3-4):377-9. PubMed ID: 7165382
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
    De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
    J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of etretinate, acitretin and their metabolites in perfusate, perfusate plasma, bile or hepatic tissue with reversed-phase high-performance liquid chromatography.
    Decker MA; Zimmerman CL
    J Chromatogr B Biomed Appl; 1995 May; 667(1):105-13. PubMed ID: 7663673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
    Besner JG; Meloche S; Leclaire R; Band P; Mailhot S
    J Chromatogr; 1982 Sep; 231(2):467-72. PubMed ID: 6215418
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of etretinate and its main metabolite in human plasma using normal-phase high-performance liquid chromatography.
    Paravicini U; Busslinger A
    J Chromatogr; 1983 Sep; 276(2):359-66. PubMed ID: 6630385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
    Vahlquist A; Rollman O; Pihl-Lundin I
    Acta Derm Venereol; 1986; 66(5):431-4. PubMed ID: 2431582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On metabolism and pharmacokinetics of an aromatic retinoid.
    Paravicini U; Stöckel K; MacNamara PJ; Hänni R; Busslinger A
    Ann N Y Acad Sci; 1981 Feb; 359():54-67. PubMed ID: 6942699
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma.
    Wyss R; Bucheli F
    J Chromatogr; 1988 Oct; 431(2):297-307. PubMed ID: 2977389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of etretinate on blood and liver in rats.
    Sakamoto K; Kasahara T; Nakayama S; Nakai Y; Kudo J
    Jpn J Pharmacol; 1982 Dec; 32(6):1175-8. PubMed ID: 7161968
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 18. A newly discovered xenobiotic metabolic pathway: ethyl ester formation.
    Chou RC; Wyss R; Huselton CA; Wiegand UW
    Life Sci; 1991; 49(21):PL169-72. PubMed ID: 1834900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of retinoids in plasma by high-performance liquid chromatography and automated column switching.
    Wyss R
    Methods Enzymol; 1990; 189():146-55. PubMed ID: 2292929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of oral retinoid on the cell kinetic of normal human epidermis (author's transl)].
    Gillenberg A; Immel C; Orfanos CE
    Arch Dermatol Res; 1980; 269(3):331-5. PubMed ID: 7235737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.